Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

An Overview of Psychoactive Drugs

An Overview of Psychoactive Drugs

Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...

CNS Stimulants: Psychedelic Agents

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...

Hallucinogens and Psychedelics

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...

Drug Classes and Categories

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...

Altered States of Awareness

Altered States of Awareness

Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Response to 'Comment on "Multifactorial attribution for vancomycin-associated acute kidney injury"'.

British journal of clinical pharmacology·2026

Same journal

Analysis of spontaneous reports of suspected adverse reactions related to medical cannabis from the Italian Phytovigilance System.

British journal of clinical pharmacology·2026

Same journal

UGT1A1 and irinotecan: Ready for routine pharmacogenetic care.

British journal of clinical pharmacology·2026

Same journal

Comment on 'Sequential nephron blockade vs. sequential renin-angiotensin system blockade on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial'.

British journal of clinical pharmacology·2026

Same journal

Ceftriaxone-induced liver injury: Incidence, phenotypic characterization and predictive factors.

British journal of clinical pharmacology·2026

Same journal

The quantification and epistemology of medicines use and polypharmacy tested in an observational study.

British journal of clinical pharmacology·2026

Search research articles

Related Experiment Video

Updated: Jan 3, 2026

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

Understanding the UK Psychoactive Substances Act.

Raymond G Hill¹

¹Faculty of Medicine, Imperial College, Commonwealth Building, Hammersmith Campus, Du Cane Rd, London, UK.

British Journal of Clinical Pharmacology

|November 22, 2019

Summary

The UK Psychoactive Substances Act 2016 aimed to control novel psychoactive substances. This review assesses its effectiveness and global context during its initial two years.

Keywords:

drug legislation novel psychoactive substances

More Related Videos

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Related Experiment Videos

Last Updated: Jan 3, 2026

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry

Published on: October 2, 2016

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Area of Science:

Pharmacology
Law
Public Health

Background:

The Psychoactive Substances Act 2016 (PSA) was enacted in the UK to address the growing issue of novel psychoactive substances.
Existing drug regulations in the UK did not adequately cover these emerging substances.
The Act's introduction followed concerns about public health risks associated with unregulated psychoactive compounds.

Purpose of the Study:

To review the legislative context and unique features of the UK Psychoactive Substances Act 2016.
To compare the PSA with international drug control strategies.
To evaluate the efficacy and impact of the PSA during its first two years of implementation.

Main Methods:

Review of the Home Office Report on the workings of the UK Psychoactive Substances Act (published November 2018).
Analysis of the legislative framework differentiating the PSA from previous UK drug laws.
Comparative assessment of the PSA against global drug control schemes.

Main Results:

The PSA 2016 represents a distinct approach to drug regulation in the UK.
The review provides an initial assessment of the Act's success in its early implementation phase.
Contextualizes the UK's legislative response within international efforts to control psychoactive substances.

Conclusions:

The Psychoactive Substances Act 2016 introduced a new regulatory paradigm for psychoactive substances in the UK.
Further evaluation is necessary to fully ascertain the long-term impact and success of the Act.
The findings contribute to understanding the challenges and strategies in regulating novel psychoactive substances globally.